Thoma Bravo Completes Acquisition of Imprivata

  • M&A Deals
  • 19.09.2016 10:30 am

Imprivata®, the healthcare IT security company, today announced the completion of its acquisition by leading private equity investment firm Thoma Bravo, LLC. Under the terms of the merger agreement, Imprivata shareholders are entitled to receive $19.25 in cash for each share of Imprivata common stock they hold.

The transaction was announced on July 13, 2016 and received approval from Imprivata shareholders on September 14, 2016. As a result of the completion of the transaction, shares of Imprivata common stock were removed from listing on the New York Stock Exchange (“NYSE”), with trading in Imprivata shares suspended prior to the opening of business today.

Barclays served as exclusive financial advisor to Imprivata, and Goodwin Procter LLP served as its legal advisor. Kirkland & Ellis LLP served as legal advisor to Thoma Bravo, and Silicon Valley Bank arranged the transaction’s debt financing.

Related News